All Stocks
S

SMMT

Summit Therapeutics Inc.
Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$19.38

Market Cap

$14.43B

Beta

-1.37

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%
EPS Growth (YoY)-100.00%
Revenue CAGR 3Y+0.00%
P/E Ratio0.0
PEG Ratio—
FCF Yield-2.24%
Debt / Equity0.03
Interest Coverage999.0x

Sign up free to unlock full analysis

  • ✓Full 24-factor quality scorecard
  • ✓AI investment committee analysis
  • ✓Factor radar & value trap detection
  • ✓10-year strategy backtesting
  • ✓Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for SMMT.